您当前的位置：
首页 >
文章列表页 >
Shuangshen Ningxin Capsules Regulates Mitochondrial Fission and Fusion to Alleviate Myocardial Ischemia-reperfusion Injury in Rats
更新时间：2024-03-04

    • Shuangshen Ningxin Capsules Regulates Mitochondrial Fission and Fusion to Alleviate Myocardial Ischemia-reperfusion Injury in Rats

      增强出版
    • “The latest research has found that Shuangshen Ningxin Capsules alleviate myocardial ischemia-reperfusion injury in rats by regulating mitochondrial fission and fusion, providing a new strategy for myocardial protection.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 7, Pages: 87-94(2024)

    • DOI：10.13422/j.cnki.syfjx.20231316    

      CLC： R284;R285;R289;R287;R22;R2-031;R33;R24

    • Received：29 May 2023，

      Published Online：19 October 2023，

      Published：05 April 2024

    移动端阅览

  • XIN Gaojie,CHEN Yuanyuan,LIU Zixin,et al.Shuangshen Ningxin Capsules Regulates Mitochondrial Fission and Fusion to Alleviate Myocardial Ischemia-reperfusion Injury in Rats[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(07):87-94. DOI： 10.13422/j.cnki.syfjx.20231316.

  •  
  •  

0

Views

136

下载量

2

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Regulation of Oxidative Stress by Traditional Chinese Medicine in Prevention and Treatment of Myocardial Ischemia-reperfusion Injury： A Review
Danhong Injection Regulates Mitochondrial Dynamics in Rat Model of Chronic Heart Failure via AMPK/Drp1 Pathway
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics
Mechanism of Danshenol A in Alleviating Myocardial Ischemia-reperfusion Injury-induced Ferroptosis of Cardiomyocytes
Mechanism of Chinese Medicine Polysaccharide in Improving Myocardial Ischemia-reperfusion Injury

Related Author

ZHAO Haosen
REN Weijie
LI Jiahao
WANG Peili
YE Jiahao
WU Zizheng
ZHANG Yao
MENG Lichong

Related Institution

Affiliated Hospital of Shanxi University of Chinese Medicine
Shanxi University of Chinese Medicine
Hunan University of Chinese Medicine
Natural History Museum of China
Beijing Key Laboratory of Chinese Materia Pharmacology，National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences
0